Acasti Pharma (NASDAQ: ACST) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Date, Research Firm, Action, Current, Target Acasti Pharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. 23 Jan 2020 Acasti Pharma (NASDAQ:ACST) seems to have found nothing but a dry Oppenheimer analyst put a $7 per-share price target on ACST stock. 12 Mar 2020 Additionally, ACST shares got another “Outperform” rating from Oppenheimer, setting a target price of $7 on the company's shares, according to
Acasti Pharma Inc., ACST Advanced Chart - (NAS) ACST ...
ACST | Complete Acasti Pharma Inc. stock news by MarketWatch. View real-time stock Acasti Pharma stock price target cut to $2 from $8 at B. Riley FBR. Jan. Acasti Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ACST updated stock price target summary. Find the latest Acasti Pharma, Inc. (ACST) stock quote, history, news and other And Wall Street analysts see upside, with the average price target above $30, Get your free Acasti Pharma Inc stock live and up-to-date data - ACST Quote, charts, rates, analysis, news & forecasts. Enter Now! Get today's Acasti Pharma Inc stock price and latest ACST news as well as Acasti Pharma real-time stock quotes, technical analysis, full financials and more. ACASTI PHARMA INC (ACST:CV). 0.53 0.01 (1.92%). As of: 03/11/20 2:01:57 pm . REAL-TIME QUOTE. Prices update every five seconds for TSX Venture-listed
Acasti Pharma Inc Stock Price Forecast, "ACST" Predictons for2020
4 Jun 2019 Acasti Pharma Inc (NASDAQ:ACST) (CVE:ACST) CEO Jan D'Alvise speaks to Proactive's Andrew Scott after announcing their second Phase III ACST Stock Forecast - Buy or Sell? Acasti Pharma ACST Stock Forecast and Technical Analysis Sell candidate since 2020-03-27 Loss -14.18% PDF Acasti Pharma gained 4.55% in the last trading day ( Thursday, 2nd Apr 2020 ), rising from $0.33 to $0.35 During the day the stock fluctuated 15.66% from a day low at $0.31 to a day high of $0.36 . ACST Stock Price, Forecast & News (Acasti Pharma) Acasti Pharma's stock was trading at $0.3849 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACST stock has decreased by 10.4% and is now trading at $0.3450. View which stocks have … ACST Stock Price | Acasti Pharma Inc. Stock Quote (U.S ... ACST | Complete Acasti Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
The website address for Stockhouse has changed. We changed the address of the Stockhouse website from www.stockhouse.com to stockhouse.com. When …
Find the latest Earnings Report Date for Acasti Pharma, Inc. Class A Common Stock (ACST) at Nasdaq.com. Acasti Pharma, Inc. (ACST) Stock Price, Quote, History ... Find the latest Acasti Pharma, Inc. (ACST) stock quote, history, news and other vital information to help you with your stock trading and investing. Acasti Pharma, Inc. - ACST - Stock Price Today - Zacks View Acasti Pharma, Inc. ACST investment & stock information. Get the latest Acasti Pharma, Inc. ACST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Acasti Pharma Inc Stock Forecast, "ACST" Stock Predictons ... Acasti Pharma Inc Stock Price Forecast, "ACST" Predictons for2020
Get today's Acasti Pharma Inc stock price and latest ACST news as well as Acasti Pharma real-time stock quotes, technical analysis, full financials and more.
Acasti Pharma (NASDAQ: ACST) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Date, Research Firm, Action, Current, Target
Mar 05, 2020 · ACST stock historical price chart. ACST stock reached 52-week highs on December at $3.08, and all-time highs 2013-07-24 with a price of 42. ACST stock price target How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do Acasti Pharma, Inc. (ACST) Stock Forum & Discussion ... Find the latest Acasti Pharma, Inc. (ACST) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Acasti Pharma (TSXV:ACST) - Share price, News & Analysis ... Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia.